NICHD - News Releases

News Releases Search Results

Your search for: Cancer, All Years All Organizations returned the following 7 results:

07/14/09		New Technique Could Sustain Cancer Patients' Fertility
Researchers funded by the National Institutes of Health have completed a critical first step in the eventual development of a technique to retain fertility in women with cancer who require treatments that might otherwise make them unable to have children.

06/29/09		Second Gene Linked to Familial Testicular Cancer
Specific variations or mutations in a particular can gene raise a man’s risk of familial, or inherited, testicular germ-cell cancer, the most common form of this disease, according to new research by scientists at the National Institutes of Health. This is only the second gene to be identified that affects the risk of familial testicular cancer, and the first gene in a key biochemical pathway. The study appears in the July 2009 Cancer Research.

08/15/06		New Findings Offer More Complete View Of Breast Cancer Gene Mutations in U.S. Population
BETHESDA, Md., Tues., Aug. 15, 2006 - A large study funded by the National Institutes of Health today provided the clearest picture yet of the prevalence in the U.S. population of mutations in two genes associated with an increased risk of breast cancer. The genes are called Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2). In addition, the study identified key predictors for assessing which women are most likely to carry these genetic mutations.

06/12/06		Lack of Key Enzyme Associated with Development of Rare Tumor
Researchers at the National Institutes of Health have discovered that a rare tumor of the adrenal glands appears to result from a genetic deficiency of an important enzyme. The enzyme is one of a class of enzymes involved in halting a cell's response to hormones and appears to stop cells from dividing.

11/29/02		Study Confirms Breast Cancer Risk in Continuous Combined Hormone Therapy Risk Begins to Return to Normal After Women Stop Taking Hormones
Researchers confirmed that a daily, combined dose of estrogen and progestin increases breast cancer risk in post menopausal women, but added that this risk begins to return to normal about six months after women stop taking the hormones.

06/26/02		NICHD Study Finds No Association Between Oral Contraceptive Use and Breast Cancer For Women from 35 to 64
Women between the ages of 35 and 64 who took oral contraceptives at some point in their lives are no more likely to develop breast cancer than are other women the same age, according to findings from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Women's Contraceptive and Reproductive Experiences Study (Women's CARE).

06/18/02		New Study Finds Vasectomy Does Not Increase Prostate Cancer Risk
Contrary to some earlier studies, a new study funded in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) found that men who undergo vasectomies are no more likely to develop prostate cancer than are men who do not.

If you are a member of the media and have questions about an NICHD news release or research, or if you would like to schedule an interview with an NICHD scientist or grantee, please contact the Public Information and Communications Branch at 301-496-5133 or by fax at 301-496-7101.